On December 23, 2022, Nestlé Group announced it strategically invested in Xinruipeng Pet Medical Group. At the same time, Nestle Purina carried out strategic cooperation with Xinruipeng to deeply cultivate the Chinese pet market.
On December 23, 2022, Nestlé Group announced it strategically invested in Xinruipeng Pet Medical Group. At the same time, Nestle Purina carried out strategic cooperation with Xinruipeng to deeply cultivate the Chinese pet market.
Nestle Purina's History
Xinruipeng Group is a comprehensive ecological enterprise group with pet medical treatment as its main business and diversified business development. Nestle Purina is a pet food company with a history of 128 years. With evidence-based scientific research as the core driving force, Nestle is committed to "improving the quality of life of pets around the world". Nestle Purina, as the leading brand in the field of pet scientific nutrition, has been committed to all-round cooperation with the most authoritative and top local pet medical expert resources around the world to provide pets and consumers with a full range of professional services such as pet feeding, pet nutrition, pet medical treatment and pet care. This strategic cooperation with Xinruipeng in China is highly consistent with Nestle Purina's global business practice.
Peng Yonghe, chairman and president of Xinruipeng Group, said that Nestle Purina has a deep accumulation in pet nutrition and food. Taking the strategic cooperation as an opportunity, the two parties will work together to increase cooperation in the field of basic nutrition and health sciences, and provide full life cycle medical care, nutrition and health solutions for tens of millions of pets in China.
Chen Xiaodong, president of Nestle Purina China, said that Xinruipeng Group, as the leading pet medical group in China, has a wide range of top expert resources and a complete medical service ecosystem. The cooperation between Nestlé Purina and Xinruipeng will provide our pet lovers with more complete and domestic first-class products and services.
Adhering to the concept of evidence-based science, Nestle Purina has established the world's first professional pet care research center in 1926. So far, it has established 8 R&D centers in 5 continents around the world, and has brought together more than 500 top pet care professional nutrition experts. They have always been at the forefront of innovation and breakthroughs in the entire industry for a century, and have continuously refreshed industry standards.
Nestle Purina owns many world-renowned well-known brands, such as its scientific flagship brand - GN, cat wet food brand - Zhenzhi, pet dental health brand - Dental Health, etc. Its care for pets covers the multi-faceted needs of pets in the whole life cycle, such as pet staple food, snacks, prescription food, nutritional supplements, supplies and other fields.
The "fertile soil" of the Chinese pet market has huge development potential
Since entering the Chinese market, Purina has always firmly believed that the "fertile soil" of the Chinese pet market has huge development potential. In order to better serve Chinese consumers, under the guidance of the new group management, Purina has formulated a 5-year and 10-year plan to become a leading brand in the Chinese pet market, adopting a high-end and mass-market dual-wheel drive brand layout , the product layout with mutual promotion of local and international advantages, as well as the channel layout of online and offline global marketing, and invested nearly 1 billion yuan to invest in the expansion of Tianjin Purina pet food factory, integrating Purina's world-leading dry food and wet food technology Introduce local production in China to provide Chinese consumers with high-quality products and services based on evidence-based scientific formulas, high-standard raw materials, and strict production processes.
The vision of Xinruipeng Group is: to become a world-class pet comprehensive service ecological platform, to continuously explore and enhance the value connotation of animal welfare, and to build a beautiful ecology of the pet industry. The business of Xinruipeng Group covers Pet Medical Group, Runhe Supply Chain Group, Duoyue Education Group, Beast Hill Diagnostics Division, Xinruipeng Research Institute, Kaisheng Culture Media, International Hospital Division, etc. covering the main links of the pet ecological industry chain. The group has more than 1,000 pet hospitals of various types, distributed in more than 100 cities such as Beijing, Shanghai, Guangzhou, Shenzhen, Hong Kong, and Chengdu. All the business modules under the group not only serve internally, but have become an important force serving the entire industry through development in recent years.
In addition to continuously consolidating its existing business advantages, Xinruipeng Group also devotes more energy to promoting scientific research in animal medicine, not only limited to pet medical and other life science branches, but also based on Xinruipeng's unique hierarchical diagnosis and treatment structure and doctor resources, the advantages of medical big data, and strong digital capabilities to establish an innovative talent training mechanism, and carry out innovative cooperation with enterprises in medical devices, drugs, nutrition and health care, as well as universities and research institutes on cutting-edge technologies, jointly develop more and better innovative diagnostic and treatment products, accelerate the cultivation of young scientific and technological talents, and promote the innovation and development of China's pet medical technology.